The Big Biz Show interviews Jonathan C. Javitt, M.D., M.P.H. Founder, Chairman and CEO of NRx Pharmaceuticals and Co-CEO of HOPE Therapeutics, discussing the opportunity for HOPE Therapeutics in developing its nationwide network of interventional psychiatry clinics to help address the national epidemic of suicidality and mental health, the planned financing and upcoming presentations by management in San Francisco and at Mar-A-Lago.

The Big Biz Show interviews Jonathan C. Javitt, M.D., M.P.H./Chief Scientist, Director, and Founder, NRx Pharmaceuticals, discussing IV Ketamine and it’s treatment for acute suicidality, anti-depressant oral medication NRX-101 and the launch of Hope Therapeutics.

The Big Biz Show interviews Jonathan C. Javitt, M.D., M.P.H./Chief Scientist, Director, and Founder, NRx Pharmaceuticals, discussing IV Ketamine and it’s treatment for acute suicidality, anti-depressant oral medication NRX-101 and the launch of Hope Therapeutics.

The Big Biz Show interviews Jonathan C. Javitt, M.D., M.P.H./Chief Scientist, Director, and Founder, NRx Pharmaceuticals, discussing IV Ketamine and it’s treatment for acute suicidality, anti-depressant oral medication NRX-101 and the launch of Hope Therapeutics.